Multitracer studies during gene therapy of hepatoma cells with herpes simplex virus thymidine kinase and ganciclovir

Journal of Nuclear Medicine

Volumn 38, Issue 7, 1997, Pages 1048-1054

  Haberkorn, Uwe ^a   Altmann, Annette ^a   Morr, Iris ^a   Germann, Christine ^a   Oberdorfer, Franz ^a   Van Kaick, Gerhard ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Gene therapy; Glucose metabolism; Herpes simplex virus thymidine kinase; PET

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE;

AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; GENE THERAPY; GLUCOSE METABOLISM; HERPES SIMPLEX VIRUS; LIVER CELL CARCINOMA; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT;

3-O-METHYLGLUCOSE; AMINOISOBUTYRIC ACIDS; ANIMALS; ANTIVIRAL AGENTS; CARBON RADIOISOTOPES; CELL DIVISION; DEOXYGLUCOSE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORODEOXYGLUCOSE F18; GANCICLOVIR; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; LIVER NEOPLASMS, EXPERIMENTAL; METHIONINE; RATS; SIMPLEXVIRUS; THYMIDINE KINASE; TOMOGRAPHY, EMISSION-COMPUTED; TUMOR CELLS, CULTURED;

EID: 0030872422     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Keller PM, Fyfe JA, Beauchamp L, et al. Enzymatic phosphorylation of acyclic nucleoside analogs and correlations with antiherpetic activities. Biochem Pharmacol 1981;30:3071-3077.
2. Moolten FL. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 1986;46:5276-5281.
3. Culver KW, Ram Z, Walbridge S, et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 1992;256:1550-1552.
4. Ram Z, Culver WK, Walbridge S, et al. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res 1993;53:83-88.
5. Takamiya Y, Short MP, Ezzedine ZD, Moolten FL, Breakfield XO, Martuzza RL. Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells. J Neurosci Res 1992;33:493-503.
6. Huber BE, Richards CA, Krenitsky TA. Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy. Proc Natl Acad Sci USA 1991;88:8039-8043.
7. Vile RG, Hart IR. Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA. Cancer Res 1993;53:3860-3864.
8. 3H-5-fluorocytosine. J Nucl Med 1996;37:87-94.
9. Wahl RL, Cody RL, Hutchins CD, Mudgett EE. Primary and metastatic breast carcinoma: initial evaluation with PET with the radiolabeled glucose analog 2-(F-18)-fluoro-2-deoxy-D-glucose. Radiology 1991;179:765-770.
10. Haberkorn U, Strauss LG, Dimitrakopoulou A, et al. Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy. J Nucl Med 1993;34:12-17.
11. Rozenthal JM, Levine RL, Nickles RJ, Dobkin JA. Glucose uptake by gliomas after treatment. Arch Neurol 1989;46:1302-1307.
12. Minn H, Paul R, Ahonen A. Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18-fIuorodeoxyglucose. J Nucl Med 1988;29:1521-1525.
13. Bergstrom M, Muhr C, Lundberg PO, et al. Rapid decrease in amino acid metabolism in prolactin-secreting pituitary adenomas after bromocriptine treatment: a PET study. J Comput Assist Tomogr 1987;11:815-819.
14. Jansson T, Westlin JE, Ahlstrom H, Lilja A, Langstrom B, Bergh J. Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation? J Clin Oncol 1995;13:1470-1477.
15. 11C)methionine: a preliminary study. Eur J Nucl Med 1993;6:495-501.
16. Haberkorn U, Altmann A, Morr I, et al. Gene therapy with herpes simplex virus thymidine kinase in hepatoma cells: uptake of specific substrates. J Nucl Med 1997;38:287-294.
17. Haberkorn U, Morr I, Oberdorfer F, et al. Fluorodeoxyglucose uptake in vitro: aspects of method and effects of treatment with gemcitabine. J Nucl Med 1994;35:1842-1850.
18. Haberkorn U, Reinhardt M, Strauss LG, et al. Metabolic design of combination therapy: use of enhanced fluorodeoxyglucose uptake caused by chemotherapy. J Nucl Med 1992;33:1981-1987.
19. Oberdorfer F, Kemper K, Kaleja M, Reusch J, Gottschall K. Carbohydrate analysis with ion chromatography using eurokat stationary phases: preparative separation of monosaccharides and their fluorinated derivatives. J Chromatogr 1991;552:483-487.
20. Higashi PC, Clavo AC, Wahl RL. In vitro assessment of 2-fluoro-2-deoxy-D-glucosc, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy. J Nucl Med 1993;34:773-779.
21. Schaider H, Haberkorn U, Berger MR, Oberdorfer F, Morr I, van Kaick G. Application of α-aminoisobutyric acid, L-methionine, thymidine and 2-fluoro-2-deoxy-D-glucose to monitor effects of chemotherapy in a human colon carcinoma cell line. Eur J Nucl Med 1996;23;55-60.
22. 14C)-glucose during chemotherapy in murine Lewis lung tumor. Nucl Med Biol 1992;19:55-63.
23. Slosman DO, Pugin J. Lack of correlation between tritiated deoxyglucose, thallium-201 and technetium-99m-MIBI cell incorporation under various cell stresses. J Nucl Med 1994;35:120-126.
24. Wertheimer E, Sasson S, Cerasi E, Ben-Neriah Y. The ubiquitous glucose transporter GLUT-1 belongs to the glucose-regulated protein family of stress-inducible proteins. Proc Natl Acad Sci USA 1991;88:2525-2529.
25. Widnell CC, Baldwin SA, Davies A, Martin S, Pasternak CA. Cellular stress induces a redistribution of the glucose transporter. FASEB J 1990;4:1634-1637.
26. Pasternak CA, Aiyathurai JEJ, Makinde V, et al. Regulation of glucose uptake by stressed cells. J Cell Physiol 1991;149:324-331.
27. Clancy BM, Czech MP. Hexose transport stimulation and membrane redistribution of glucose transporter isoforms in response to cholera toxin, dibutyryl cyclic AMP and insulin in 3T3 adipocytes. J Biol Chem 1990;265:12434-12443.
28. Hariharan R, Bray M, Ganim R, Doenst T, Goodwin GW, Taegtmayer H. Fundamental limitations of (18F)2-deoxy-2-fluoro-D-glucose for assessing myocardial glucose uptake. Circulation 1995;91:2435-2444.
29. 3H]thymidine and gallium-67. J Nucl Med 1991;32:2118-2123.
30. Christensen HN. Role of amino acid transport and countertransport in nutrition and metabolism. Physiol Rev 1990;70:43-76.
31. Conti PS, Sordillo EM, Sordillo PP, Schmall B. Tumor localization of alpha-aminoisobutyric acid (AIB) in human melanoma heterotransplants. Eur J Nucl Med 1985;10:45-47.
32. 11C in normal and prostate cancer hearing rat after chemotherapy. Eur J Nucl Med 1981;6:535-538.
33. Scanion K, Safirstein RL, Thies H, ross RB, Waxman S, Guttenplan JB. Inhibition of amino acid transport by eis-diaminedichloroplatinum (II) derivatives L1210 murine leukemia cells. Cancer Res 1983;43:4211-4215.
34. Scanion K, Cashmore AR, Kashani-Sabet M, et al. Inhibition of methionine uptake by methotrexate in mouse leukemia L1210. Cancer Chemother Pharmacol 1987;19:21-24.
35. Hoffman RM. Altered inethionine metabolism and transmethylation in cancer. Anticancer Res 1985;5:1-30.
36. Higashi K, Clavo AC, Wahl RL, Does FDG uptake measure the proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. J Nucl Med 1993;34:414-418.